A gibberellic acid product can leave the factory at full strength and reach the sprayer with much less activity, because the molecule decays in water. Gibberellic acid formulation is therefore a stability problem as much as a solubility problem. Every common product type, from tablets to soluble powders to liquids, is a different answer to the same pair of constraints. This guide explains the chemistry behind GA3 solubility and hydrolysis, compares the formulation types with their trade-offs and covers stabilisation, quality control and regulation. It draws on an EFSA peer review, peer-reviewed literature, patent background and the Indian register, with formulation experience from Global Formulation behind it.
Gibberellic acid (GA3) is a tetracyclic diterpenoid carboxylic acid made by fermentation of Fusarium fujikuroi, according to a 2024 review in the Journal of Fungi. The molecule carries a double bond, a secondary and a tertiary alcohol, a γ-lactone ring and a carboxyl group. Each group matters to a formulator: the carboxyl group sets its acid-base behaviour, and the review states that loss of the γ-lactone ring is the biological inactivation of GA3. The table collects the physical data that the formulator needs.
| Property | Value Reported | Source |
|---|---|---|
| Acid strength | pKa 4.1 at 25 °C, a weak acid | EFSA 2024; PPDB |
| Water solubility | 4,280 mg/L at 20 °C and pH 7 | PPDB, EU regulatory data |
| Octanol-water partition | log P 0.72 | PPDB |
| Thermal behaviour | Decomposes before melting; degradation point above 200 °C | PPDB, EU regulatory data |
| Organic solvents | Dissolves in alcohol, acetone, ethyl acetate and butyl acetate; limited in benzene and chloroform | Journal of Fungi 2024 |
| Dry state | Stable under dry conditions | Journal of Fungi 2024 |
| Aqueous state | Decomposes quickly at high temperature, at alkaline pH and in aqueous solution | Journal of Fungi 2024 |
The Pesticide Properties Database entry draws these values from EU regulatory data. The EFSA 2024 peer review gives the same pKa. Solubility is the first constraint, and it interacts with pH.
At pH 7 and 20 °C GA3 dissolves to about 4.3 g/L in water, which is low for a concentrate. Because it is a weak acid with a pKa of 4.1, it ionises and dissolves more readily as the pH rises. Higher pH is also where the molecule degrades, so a formulator cannot simply raise the pH to dissolve more. Solvents offer the other route, and they bring limits of their own.
The stability side of that compromise needs its own look.
Gibberellic acid is stable dry and unstable in water, and that single fact shapes every product type. The 1958 Merck patent states that in water solution the gibberellic acid compounds lose their growth-stimulant activity quite rapidly on standing. A 2024 review adds that GA3 decomposes quickly at high temperatures and alkaline pH as well as in aqueous solution. The modern patent describes very low solubility combined with undesirable hydrolysis as the reason aqueous GA3 formulations are especially difficult.
The sources read for this article give no universal half-life, so stability has to be measured in the actual formulation, pack and storage conditions.
With the constraints set, the product types can be compared.
Gibberellins have been formulated as solutions, soluble powders, wettable powders, tablets and water-dispersible granules, according to the same patent background. The Pesticide Properties Database lists granules, water-soluble tablets, soluble powders and soluble crystal formulations as available forms. The Indian register of major uses, in a March 2024 extract, lists gibberellic acid technical and formulations coded as liquid, granule, soluble powder and water-soluble granule. Each type answers the solubility and stability limits differently.
| Type | How It Handles Solubility and Hydrolysis | Trade-Offs Reported |
|---|---|---|
| Liquid (solution) | Holds GA3 dissolved in a solvent system, so there is no dissolution step in the tank | Low solubility limits strength; limited storage stability; VOC and flammability concerns |
| Soluble powder | Dissolves to a true solution, with no further agitation of the tank-mix | Dust on handling; poor wetting and slow dissolution |
| Tablet | Pre-measured dose; effervescent versions dissolve in two to ten minutes | Highly susceptible to humidity; can be slow to dissolve and costly; not ideal for large-scale field work |
| Water-dispersible granule | Dry granule, usually no more than eight percent moisture, that disperses in water | Needs agitation; quality depends on process and active; can leave insoluble residues |
The trade-offs in the table come from the patent background, which is one applicant's description of earlier products. Treat them as questions to test, not as measured facts. Our guides to effervescent tablet formulation, soluble liquid and soluble granule formulation and wettable powder and water-dispersible granule formulation cover the manufacturing side of each type.
Whichever type is chosen, the stabilisation strategy decides its shelf life.
One early solution is also the clearest: keep the active in a dry, compatible carrier. The 1958 Merck patent states that anhydrous extenders are important and that many water-soluble substances that look suitable prove incompatible with gibberellic acid compounds. It reports diammonium phosphate as a water-soluble solid carrier and stabiliser that no other tested carrier approached. That is a 1958 claim, so any carrier choice today needs fresh stability data.
A stable product still has to meet a specification, which for GA3 is a regulatory document.
No FAO specification exists for gibberellic acid, according to the EFSA 2024 peer review. EFSA proposes a unified EU reference specification that keeps the minimum purity of the active substance as manufactured at 850 g/kg. It adds fumonisin B1 and B2 as relevant impurities, with their sum not to exceed 200 µg/kg. HPLC-UV methods are available for GA3 content in the technical material and in the formulation for representative use.
Regulation sets the frame in which those specifications are used.
The EFSA 2024 conclusion rests on the representative use of gibberellic acid as a plant growth regulator on seedless grapes in the field. It found no critical areas of concern for the identity, physical, chemical and technical properties of the substance or for the formulation and analytical methods of that use. It also lists data gaps, including the nature of residues, the aerobic degradation route in soil and an impurity method for the formulation. Registration then proceeds product by product, crop by crop and country by country.
Because registration is specific to product, crop and country, the regulatory route belongs in the development plan from the start.
Choosing a GA3 formulation type works best as a sequence of questions, because the stability limits remove options before cost does. The order below runs from the market to the pack and ends with the stability study. Each step points back to a section above. The sequence suits a formulator, a registrant or a brand owner briefing a development partner.
Followed in this order, the sequence turns a list of product types into a design that the chemistry, the pack and the regulator all accept.
Gibberellic acid sits between fermentation chemistry, solid-state stability and registration, so an agrochemical formulation consultant works across all three. A brief usually starts with the technical material, the target formulation type and the market. Agrochemical product development services then carry the work from bench stability trials to pilot batches. A contract formulation agrochemical manufacturer can handle scale-up and supply.
The full range of services sits under agro chemicals, and our overview of agrochemical technology and formulations shows how the product families connect. Before approaching a consultant, collect the technical material specification, the target formulation type, the markets and registration routes and any stability problems seen so far.
GA3 dissolves to only about 4.3 g/L in water at pH 7 and 20 degrees Celsius, and it degrades in water, especially at alkaline pH. A gibberellin formulation patent describes very low solubility and undesirable hydrolysis as the reason aqueous GA3 formulations are especially difficult. Solvents that dissolve more GA3 bring flammability, corrosivity or VOC problems. Most products therefore keep the active dry until the moment of dissolution in the tank.
GA3 is stable under dry conditions but decomposes quickly in aqueous solution, at alkaline pH and at high temperature, according to a 2024 review. A 1993 HPLC study showed that GA3 transforms to a dicarboxylic acid via iso-GA3 in weak alkaline solution, and that product has about 20 percent of the bioactivity of GA3. The sources read give no single half-life, so measure stability in the actual formulation, pack and storage conditions.
Patent background lists solutions, soluble powders, wettable powders, tablets and water-dispersible granules. The Pesticide Properties Database lists granules, water-soluble tablets, soluble powders and soluble crystal forms. The Indian register of major uses lists technical gibberellic acid and formulations coded as liquid, granule, soluble powder and water-soluble granule. Each type trades dust, wetting, humidity sensitivity, residues or strength against the solubility and stability limits.
A gibberellin formulation patent states that effervescent tablets are highly susceptible to humidity and can be slow to dissolve and costly. It also says tablets suit small areas and are not ideal for large-scale field operations. Because GA3 is stable dry and unstable in water, tablet stability depends on low moisture at manufacture and moisture-barrier packaging. Any buffer or effervescent couple needs its own stability test, since alkaline conditions drive decomposition.
GA3 is made by fermentation of Fusarium fujikuroi. A 2024 review notes that some Fusarium strains carry the gene for fumonisin production and that Fusarium moniliforme is well known for fumonisins B1 and B2. EFSA's 2024 peer review proposes a reference specification that names fumonisin B1 and B2 as relevant impurities, with their sum not to exceed 200 micrograms per kilogram. It also notes that a method for these impurities in the formulation is missing.
No. The EFSA 2024 peer review states that a FAO specification does not exist for this substance. The EU instead works from a reference specification, which proposes a minimum purity of 850 g/kg for the active substance as manufactured. A formulator should therefore check the specification that applies in each target market and agree analytical methods with the producer.
Not by itself. Alkaline conditions drive GA3 decomposition, but a 1958 patent lists the normally acidic condition of foliar fertilisers, together with nitrate and traces of moisture, among the contributors to instability. Dry conditions are the reliable stable state. Test the real combination of carrier, moisture and pH in the final pack.
A consultant matches the formulation type to the market and climate, then designs carrier, moisture, pH and packaging choices around the weak point of GA3. The same work sets the specification, the content method and storage protocols. Agrochemical product development services extend this to tank-mix checks and registration support, and a contract formulation agrochemical manufacturer then handles scale-up and supply.
Global Formulation supports agrochemical makers with GA3 formulation type selection, moisture and pH stability studies, specifications and storage protocols, tank-mix checks and scale-up to a contract manufacturing partner.
Talk to Our Formulation Team